275 related articles for article (PubMed ID: 31164072)
1. Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke.
Kobayashi S; Fukuma S; Ikenoue T; Fukuhara S; Kobayashi S
Stroke; 2019 Jul; 50(7):1805-1811. PubMed ID: 31164072
[TBL] [Abstract][Full Text] [Related]
2. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
Kamouchi M; Sakai H; Kiyohara Y; Minematsu K; Hayashi K; Kitazono T
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
[TBL] [Abstract][Full Text] [Related]
3. Clinical Effects of Early Edaravone Use in Acute Ischemic Stroke Patients Treated by Endovascular Reperfusion Therapy.
Enomoto M; Endo A; Yatsushige H; Fushimi K; Otomo Y
Stroke; 2019 Mar; 50(3):652-658. PubMed ID: 30741623
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
Tanahashi N; Yamaguchi T; Awano H; Matsuda H
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
[TBL] [Abstract][Full Text] [Related]
8. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
Tsukamoto Y; Takizawa S; Takahashi W; Mase H; Miyachi H; Miyata T; Takagi S
J Stroke Cerebrovasc Dis; 2011; 20(2):111-6. PubMed ID: 20580255
[TBL] [Abstract][Full Text] [Related]
9. Effect of edaravone on favorable outcome in patients with acute cerebral large vessel occlusion: subanalysis of RESCUE-Japan Registry.
Miyaji Y; Yoshimura S; Sakai N; Yamagami H; Egashira Y; Shirakawa M; Uchida K; Kageyama H; Tomogane Y
Neurol Med Chir (Tokyo); 2015; 55(3):241-7. PubMed ID: 25739433
[TBL] [Abstract][Full Text] [Related]
10. Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE Study.
Kvistad CE; Logallo N; Oygarden H; Thomassen L; Waje-Andreassen U; Naess H
Cerebrovasc Dis; 2013; 36(5-6):351-4. PubMed ID: 24192488
[TBL] [Abstract][Full Text] [Related]
11. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
Yamaguchi T; Awano H; Matsuda H; Tanahashi N;
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
[TBL] [Abstract][Full Text] [Related]
12. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry.
Kamouchi M; Matsuki T; Hata J; Kuwashiro T; Ago T; Sambongi Y; Fukushima Y; Sugimori H; Kitazono T;
Stroke; 2011 Oct; 42(10):2788-94. PubMed ID: 21817134
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of leukoaraiosis burden and chronological age on neurological deficit recovery and 90-day outcome after minor ischemic stroke.
Onteddu SR; Goddeau RP; Minaeian A; Henninger N
J Neurol Sci; 2015 Dec; 359(1-2):418-23. PubMed ID: 26476774
[TBL] [Abstract][Full Text] [Related]
14. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.
Gill D; Cox T; Aravind A; Wilding P; Korompoki E; Veltkamp R; Kar A
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1539-43. PubMed ID: 27053029
[TBL] [Abstract][Full Text] [Related]
15. Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke.
Nakase T; Yoshioka S; Suzuki A
BMC Neurol; 2011 Mar; 11():39. PubMed ID: 21447190
[TBL] [Abstract][Full Text] [Related]
16. Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke.
Nelson S; Cloonan L; Kanakis AS; Fitzpatrick KM; Shideler KI; Perilla AS; Furie KL; Rost NS
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2519-25. PubMed ID: 27444522
[TBL] [Abstract][Full Text] [Related]
17. Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Papadopoulou M; Kostaki S; Dourliou V; Papagianni M; Savopoulos C; Hatzitolios AI
Am J Hypertens; 2015 Jun; 28(6):765-71. PubMed ID: 25468807
[TBL] [Abstract][Full Text] [Related]
18. Associations between Uric Acid Level and 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with/without Edaravone.
Naganuma M; Inatomi Y; Nakajima M; Yonehara T; Ando Y
Cerebrovasc Dis; 2018; 45(3-4):115-123. PubMed ID: 29558754
[TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
20. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
Wada T; Yasunaga H; Inokuchi R; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
J Neurol Sci; 2014 Oct; 345(1-2):106-11. PubMed ID: 25085762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
